Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse

Genes Chromosomes and Cancer

Volumn 50, Issue 3, 2011, Pages 186-195

  Gilbert, Duncan C ^a,b   McIntyre, Alan ^a   Summersgill, Brenda ^a   Missiaglia, Edoardo ^a   Goddard, Neil C ^a   Chandler, Ian ^c   Huddart, Robert A ^d   Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; OCTAMER TRANSCRIPTION FACTOR 4; PARAFFIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; RNA; TUMOR MARKER;

ADULT; ALLELIC IMBALANCE; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CARCINOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYONAL CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE EXPRESSION; GENE LOSS; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TESTIS CARCINOMA;

ADULT; ALLELIC IMBALANCE; CARCINOMA, EMBRYONAL; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 22; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; GTP-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS; RECURRENCE; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 78650959224     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20843     Document Type: Article

References (45)

1. Atkin NB, Baker MC. 1982. Specific chromosome change, i(12p), in testicular tumours? Lancet 2: 1349.
2. Atkin NB, Baker MC. 1983. i(12p): Specific chromosomal marker in seminoma and malignant teratoma of the testis? Cancer Genet Cytogenet 10: 199-204.
3. Baldassarre G, Romano A, Armenante F, Rambaldi M, Paoletti I, Sandomenico C, Pepe S, Staibano S, Salvatore G, De Rosa G, Persico, M. G. Viglietto, G. 1997. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 15: 927-936.
4. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. 1998. Increasing complexity of Ras signaling. Oncogene 17: 1395-1413.
5. De Miguel MP, Cheng L, Holland EC, Federspiel MJ, Donovan PJ. 2002. Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer. Proc Natl Acad Sci USA 99: 10458-10463.
6. Di Vizio D, Cito L, Boccia A, Chieffi P, Insabato L, Pettinato G, Motti ML, Schepis F, D'Amico W, Fabiani F, Tavernise B. Venuta S, Fusco A, Viglietto, G. 2005. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24: 1882-1894.
7. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA, Andrews PW. 2004. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22: 53-54.
8. Fedele M, Franco R, Salvatore G, Paronetto MP, Barbagallo F, Pero R, Chiariotti L, Sette C, Tramontano D, Chieffi G, Fusco A, Chieffi P. 2008. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol 215: 39-47.
9. Gilbert D, Chandler I, McIntyre A, Goddard N, Gabe R, Huddart R, Shipley J. 2009. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents. J Pathol 217: 94-102.
10. Hall A. 1994. A biochemical function for ras-At last. Science 264: 1413-1414.
11. He X, Zhu Z, Johnson C, Stoops J, Eaker AE, Bowen W, DeFrances MC. 2008. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. Cancer Res 68: 5591-5598.
12. Henegariu O, Heerema NA, Thurston V, Jung SH, Pera M, Vance GH. 2004. Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization. Cancer Genet Cytogenet 148: 14-20.
13. Henegariu O, Vance GH, Heiber D, Pera M, Heerema NA. 1998. Triple-color FISH analysis of 12p amplification in testicular germ-cell tumors using 12p band-specific painting probes. J Mol Med 76: 648-655.
14. Honecker F, Wermann H, Mayer F, Gillis AJ, Stoop H, van Gurp RJ, Oechsle K, Steyerberg E, Hartmann JT, Dinjens WN, Oosterhuis JW, Bokemeyer C, Looijenga, LH. 2009. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol 27: 2129-2136.
15. Horwich A, Shipley J, Huddart R. 2006. Testicular germ-cell cancer. Lancet 367: 754-765.
16. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. 2002. Fully automatic quantification of microarray image data. Genome Res 12: 325-332.
17. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC. 2004. KIT mutations are common in testicular seminomas. Am J Pathol 164: 305-313.
18. Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. 2008. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer 47: 43-55.
19. Li J, Xia F, Li WX. 2003. Coactivation of STAT and Ras is required for germ cell proliferation and invasive migration in Drosophila. Dev Cell 5: 787-798.
20. Mandoky L, Geczi L, Bodrogi I, Toth J, Bak M. 2003. Expression of HER-2/neu in testicular tumors. Anticancer Res 23: 3447-3451.
21. McIntyre A, Gilbert D, Goddard N, Looijenga L, Shipley J. 2008. Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults. Genes Chromosomes Cancer 47: 547-57.
22. McIntyre A, Summersgill B, Grygalewicz B, Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R, Cooper C, Clark J. Oosterhuis JW, Looijenga LH, Shipley J. 2005a. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65: 8085-8089.
23. McIntyre A, Summersgill B, Lu YJ, Missiaglia E, Kitazawa S, Oosterhuis JW, Looijenga LH, Shipley J. 2007. Genomic copy number and expression patterns in testicular germ cell tumours. Br J Cancer 97: 1707-1712.
24. McIntyre A, Summersgill B, Spendlove HE, Huddart R, Houlston R, Shipley J. 2005b. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 7: 1047-1052.
25. Missiaglia E, Selfe J, Hamdi M, Williamson D, Schaaf G, Fang C, Koster J, Summersgill B, Messahel B, Versteeg R, Pritchard-Jones K, Kool M, Shipley J. 2009. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development. Genes Chromosomes Cancer 48: 455-467.
26. Moe-Behrens GH, Klinger FG, Eskild W, Grotmol T, Haugen TB, De Felici M. 2003. Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 17: 2630-2638.
27. Moul JW, Theune SM, Chang EH. 1992. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization. Genes Chromosomes Cancer 5: 109-118.
28. Nichols CR, Kollmannsberger C. 2009. Vox populi: Using community-based studies to determine best management of early-stage nonseminoma. J Clin Oncol 27: 2114-2116.
29. Olie RA, Looijenga LH, Boerrigter L, Top B, Rodenhuis S, Langeveld A, Mulder MP, Oosterhuis JW. 1995. N- and KRAS mutations in primary testicular germ cell tumors: Incidence and possible biological implications. Genes Chromosomes Cancer 12: 110-116.
30. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostat 5: 557-572.
31. Oosterhuis JW, Looijenga LH. 2005. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222.
32. Rodriguez S, Jafer O, Goker H, Summersgill BM, Zafarana G, Gillis AJ, van Gurp RJ, Oosterhuis JW, Lu YJ, Huddart R, Cooper CS, Clark J, Looijenga LH, Shipley JM. 2003. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22: 1880-1891.
33. Roelofs H, Mostert MC, Pompe K, Zafarana G, van Oorschot M, van Gurp RJ, Gillis AJ, Stoop H, Beverloo B, Oosterhuis JW, Bokemeyer C, Looijenga LH. 2000. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 157: 1155-1166.
34. Sandberg AA, Meloni AM, Suijkerbuijk RF. 1996. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J. Urol. 155: 1531-1556.
35. Sazuka T, Tomooka Y, Ikawa Y, Noda M, Kumar S. 1992. DRG: A novel developmentally regulated GTP-binding protein. Biochem Biophys Res Commun 189: 363-370.
36. Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O, Kallioniemi O, Lothe RA. 2006. Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol 28: 315-326.
37. Sommerer F, Hengge UR, Markwarth A, Vomschloss S, Stolzenburg JU, Wittekind C, Tannapfel A. 2005. Mutations of BRAF and RAS are rare events in germ cell tumours. Int J Cancer 113: 329-335.
38. Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ. 1991. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51: 1811-1816.
39. Summersgill B, Clark J, Shipley J. 2008. Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays. Nat Protoc 3: 220-234.
40. Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. 1998. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 77: 305-313.
41. Ura K, Obama K, Satoh S, Sakai Y, Nakamura Y, Furukawa Y. 2006. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma. Clin Cancer Res 12: 6611-6616.
42. van der Horst EH, Chinn L, Wang M, Velilla T, Tran H, Madrona Y, Lam A, Ji M, Hoey TC, Sato AK. 2009. Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia 11: 355-364.
43. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Albers P, Habbema JD. 2003. Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21: 4092-4099.
44. Zafarana G, Grygalewicz B, Gillis AJ, Vissers LE, van de Vliet W, van Gurp RJ, Stoop H, Debiec-Rychter M, Oosterhuis JW, van Kessel AG, Schoenmakers EF, Looijenga LH, Veltman JA. 2003. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 22: 7695-7701.
45. Zhu Z, He X, Johnson C, Stoops J, Eaker AE, Stoffer DS, Bell A, Zarnegar R, DeFrances MC. 2007. PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein. Biochem Biophys Res Commun 358: 66-72.